<?xml version="1.0" encoding="iso-8859-1" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>Pharmalicensing.com: Industry news</title>
		<link>http://pharmalicensing.com/rss/</link>
		<description>Latest market and business intelligence from the leading publishers worldwide.</description>
		<language>en-us</language>
		<image>
			<title>Pharmalicensing.com: Industry news</title>
			<link>http://pharmalicensing.com/rss/</link>
			<url>http://pharmalicensing.com/images/pharmalicensing_logo.gif</url>
			<width>144</width>
		</image>
							<item>
				<title>Preliminary Data from Experimental Study Demonstrate Increased Mortality in Stroke Patients Treated With Epoetin Alfa</title>
				<description>BRIDGEWATER, NJ -- (September 17, 2008) -- Ortho Biotech has become aware of preliminary data from an investigator-initiated experimental study of the effects of Epoetin alfa in patients with acute...</description>
				<link>http://pharmalicensing.com/redirs/news_rss//public/news/view/441350/6</link>
				<guid>http://pharmalicensing.com/redirs/news_rss//public/news/view/441350/6</guid>
			</item>
				<item>
				<title>ANGIOTECH&amp;#039;S CORPORATE PARTNER, COOK MEDICAL, COMPLETES ENROLLMENT IN FIRST INTERNATIONAL TRIAL OF DRUG-ELUTING PERIPHERAL STENT AND FILES FOR CE MARK IN EUROPE</title>
				<description>VANCOUVER, BC, September 10, 2008 - Angiotech Pharmaceuticals, Inc. (&amp;quot;Angiotech&amp;quot;) (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company, today announced that its...</description>
				<link>http://pharmalicensing.com/redirs/news_rss//public/news/view/440122/6</link>
				<guid>http://pharmalicensing.com/redirs/news_rss//public/news/view/440122/6</guid>
			</item>
				<item>
				<title>Alsius Corporation Receives 510(K) Market Clearance for Solex(TM) Catheter</title>
				<description>IRVINE, Calif., Aug 26, 2008-- Alsius Corporation (Nasdaq: ALUS), the worldwide leader in intravascular temperature management (IVTM(TM)) therapies, today announced that the U.S. Food and Drug...</description>
				<link>http://pharmalicensing.com/redirs/news_rss//public/news/view/440687/6</link>
				<guid>http://pharmalicensing.com/redirs/news_rss//public/news/view/440687/6</guid>
			</item>
				<item>
				<title>Novacea Update on Asentar(TM)</title>
				<description>SOUTH SAN FRANCISCO, CA - September 11, 2008 -- Novacea, Inc. (NASDAQ: NOVC), today reported that it has received notice from the United States Food and Drug Administration (FDA) that the agency has...</description>
				<link>http://pharmalicensing.com/redirs/news_rss//public/news/view/440235/6</link>
				<guid>http://pharmalicensing.com/redirs/news_rss//public/news/view/440235/6</guid>
			</item>
				<item>
				<title>Approval for silver wound gel</title>
				<description>September 11, 2008--Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global medical technology company, is pleased to announce that its silver anti-microbial wound gel has received...</description>
				<link>http://pharmalicensing.com/redirs/news_rss//public/news/view/440140/6</link>
				<guid>http://pharmalicensing.com/redirs/news_rss//public/news/view/440140/6</guid>
			</item>
					<atom:link href="http://pharmalicensing.com/public/rss/news/most_viewed/6" rel="self" type="application/rss+xml" />
	</channel>
</rss>
